Passions

Travelling

Sports

Books

Experience

Vicebio to Be Acquired by Sanofi for $1.6 Billion

July 25, 2025

Cooley advised Medicxi and other venture capital investors in Sanofi’s $1.6 billion acquisition of Vicebio, a biopharmaceutical company that develops novel vaccines against life-threatening respiratory viral infections.

Read more

Related contacts

Russell Anderson
Partner, London
Simon Amies
Partner, London
Mark Jones
Associate, London
Charity Williams
Partner, San Diego
Emily Mason
Special Counsel, Santa Monica
Joe Sandys
Special Counsel, London
Jack Jones
Special Counsel, London
Eerik Kukebal
Associate, London

Related Practices & Industries

EsoBiotec Announces up to $1 Billion Acquisition by AstraZeneca

March 17, 2025

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to $1 billion on a cash- and debt-free basis.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Simon Amies
Partner, London
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Charlie Lightfoot
Partner, London
Alessandra Murata
Partner, Palo Alto
Guadalupe Sampedro
Partner, London
Stella Sarma
Partner, Brussels
Leo Spicer-Phelps
Partner, London
Nicola Squire
Partner, London
Chris Stack
Partner, London
Jeffrey J. Tolin
Partner, New York
David Wilson
Partner, London
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jack Jones
Special Counsel, London
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kafeel Azher
Associate, London
Sarah Buchik
Associate, New York
Mari Dugas
Associate, Washington, DC
Michael Fernando
Associate, London
Athina Gaki
Associate, Brussels
Elaine Huang
Associate, Palo Alto
Mark Jones
Associate, London
Eerik Kukebal
Associate, London
Chris Lynn
Associate, London
Morgan McCormack
Associate, London
Daniel Millard
Associate, London
Lindsey O'Crump
Associate, Washington, DC
Alexandra Paterson
Associate, London
Zhijing Yu
Associate, Singapore
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

AviadoBio Announces Exclusive Option and License Agreement With Astellas

October 11, 2024

Cooley advised AviadoBio, a company focused on gene therapy for neurodegenerative disorders, on its exclusive option and license agreement with Astellas Pharma for AVB-101, an investigational, adeno-associated virus (AAV)-based gene therapy in Phase 1/2 development for patients with frontotemporal dementia with progranulin mutations (FTD-GRN).

Read more

Related contacts

Frances Stocks Allen
Partner, London
Alan W. Tamarelli
Partner, New York
Tom Goodman
Partner, London
Joe Sandys
Special Counsel, London
Mark Jones
Associate, London

Related Practices & Industries

Cybersecurity Startup Snyk Acquires Cloud Security and Compliance Company Fugue

February 18, 2022

Cooley advised Snyk, a leader in developer security, on its acquisition of Fugue, a cloud security and compliance company. Partners Ian Nussbaum and Ben Shribman led the Cooley team advising Snyk.

Read more

Related contacts

Ben Shribman
Partner, London
Ryan Naftulin
Partner, Washington, DC
Meredith Klionsky
Special Counsel, Washington, DC
Nyron J. Persaud
Partner, New York
Ross Eberly
Partner, Santa Monica
Charles Haley
Partner, Palo Alto
Stephanie Gentile
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Christopher Hutter
Partner, Reston
Bridget R. Reineking
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Stella Sarma
Partner, Brussels
Chris Chynoweth
Special Counsel, New York
Megan Drill
Associate, San Diego
Eileen Leman
Associate, Los Angeles
Rick Jantz
Associate, Santa Monica
Judd Lauter
Special Counsel, San Francisco
Nicola Squire
Partner, London
Mark Jones
Associate, London
Rubin Waranch
Associate, Colorado
Patricia Myers
Paralegal Specialist, Colorado
Margie Murphy
Paralegal Specialist, New York
Melissa Eskola
Paralegal Specialist, Reston

Related Practices & Industries

Snyk Hits $8.5 Billion Valuation With Series F Round

September 15, 2021

Cooley advised Snyk, a cybersecurity software startup, on its $530 million Series F financing, which brings the company’s valuation to $8.5 billion. Lawyers Ryan Naftulin, Kerry Corrigan and Mark Jones led the Cooley team advising Snyk.

Read more

Related contacts

Ryan Naftulin
Partner, Washington, DC
Mark Jones
Associate, London
David Wilson
Partner, London
Christopher Kimball
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Jack Jones
Special Counsel, London
Rick Jantz
Associate, Santa Monica
Rebecca Ross
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC

Related Practices & Industries

View more

Rankings and accolades

The Legal 500 UK: M&A (2022)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.